[Advances of researches on acupuncture treatment of Parkinson’s disease by regulating mitochondrial function].

Publication date: Jun 25, 2025

The pathological mechanism of Parkinson’s disease (PD) is complex and affected by multi-system and multi-level factors including mitochondrial dysfunction (MD). It has been demonstrated that all patients with PD have a marked loss of dopaminergic neurons in the substantial nigra pars compacta, and MD is an important initial factor causing dopaminergic neuron degeneration. Clinical practice has shown that acupuncture has a positive role in the treatment of PD. In the present article, we summed up recent research results about the mechanisms of acupuncture underlying improvement of PD from the standpoint of mitochondrial function. Acupuncture has been shown to be able in improving mitochondrial function, and restoring mitochondrial homeostasis, and protecting the normal morphological structure of mitochondria. It can also regulate the expression of peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1α), adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK), and Sirtuins (SIRT) to take part in mitochondrial biogenesis; decrease the levels of dynamin-related protein 1 (Drp1), mitochondrial fission factor (MFF), and mitochondrial fission protein 1 (Fis1) protein to preserve mitochondrial dynamic stability; and modulate the expression of PTEN-induced putative kinase 1 (PINK1), Parkin, P62, microtubule-associated protein light chain 3Ⅱ (LC3Ⅱ), and Beclin1 to promote autophagy. In addition, through controlling mitochondrial energy metabolism, preserving calcium homeostasis, reducing oxidative stress, and preventing neuronal apoptosis, acupuncture can also help improve mitochondrial dysfunction and prevent the onset and progression of PD. However, more researches are warranted to fully unravel the underlying mechanisms of acupuncture intervention before it can be popularized in clinical settings.

Concepts Keywords
Calcium Acupuncture
Homeostasis Acupuncture Therapy
Mitochondrial Animals
Parkinson Humans
Therapy Mechanism
Mitochondria
Mitochondrial function
Parkinson Disease
Parkinson’s disease
Review

Semantics

Type Source Name
disease MESH Parkinson’s disease
disease MESH mitochondrial dysfunction
disease MESH neuron degeneration
pathway KEGG Peroxisome
drug DRUGBANK Adenosine phosphate
pathway REACTOME Mitochondrial biogenesis
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Profenamine
pathway REACTOME Autophagy
pathway REACTOME Metabolism
drug DRUGBANK Calcium
disease MESH oxidative stress
pathway REACTOME Apoptosis
pathway KEGG Parkinson disease

Original Article

(Visited 9 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *